Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations

Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations

Background and Aims: The increasing prevalence and absence of effective global treatment for metabolic syndrome (MetS) are alarming given the potential progression to severe non-communicable disorders such as type 2 diabetes and nonalcoholic fatty liver disease. The purpose of this study was to inve...

Full description

Bibliographic Details
Main Authors: Mathilde Foisy Sauvé, Francis Feldman, Mireille Koudoufio, Nour-El-Houda Ould-Chikh, Lena Ahmarani, Alain Sane, Thierry N’Timbane, Ramy El-Jalbout, Nathalie Patey, Schohraya Spahis, Alain Stintzi, Edgard Delvin, Emile Levy
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Biomedicines
Subjects:
milk peptide
nutraceutical
metabolic syndrome
metabolism
insulin signaling
inflammation
Online Access:https://www.mdpi.com/2227-9059/9/9/1140

Internet

https://www.mdpi.com/2227-9059/9/9/1140

Similar Items